Title : Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events.

Pub. Date : 2018 Jun

PMID : 29703600






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 VSP inhibitors include antibodies, acting extracelluarly on VEGF, such as bevacizumab and tyrosine kinases inhibitors, acting intracellularly on the kinase domain of VEGF receptors, such as sunintib and sorafenib. Sorafenib vascular endothelial growth factor A Homo sapiens